Nanovaccine boosts immunity in sufferers of metabolic syndrome
(Cornell University) A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria - a population that shows resistance to traditional flu and polio vaccines.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Infectious Diseases | International Medicine & Public Health | Metabolic Syndrome | Nanotechnology | Polio | Polio Vaccine | Vaccines